KalVista's Chief Development Officer sold 33,800 shares of the company's stock for $905,000. The transaction was reported by KalVista (KALV).
Insider selling can sometimes be interpreted as a signal of a lack of confidence in a company's future prospects, although it can also be for personal financial reasons. This sale by a key executive at KalVista is notable given the company's focus on drug development.
Insider selling can sometimes be interpreted as a signal of a lack of confidence in a company's future prospects, although it can also be for personal financial reasons. This sale by a key executive at KalVista is notable given the company's focus on drug development.
Pick the topics you care about. Get only what matters, on your cadence.
Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.
